1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Parnell Pharmaceuticals Holdings Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2009

Location

Overland Park KS US

Primary Industry

Pharmaceuticals

Established

2009

Firm Ownership

-

Investment Team Staff

Total Staff

-

Request a demo to show more

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2012
0
-
0
-
0
-
0
-
31 Dec 2013
0
-
0
-
0
-
0
-
30 Jun 2014
7,542,600
-
(7,115,133)
(94.3%)
(5,860,098)
(77.7%)
(17,333,322)
(229.8%)
31 Dec 2014
3,662,452
-
(1,136,296)
(31%)
(444,534)
(12.1%)
(1,428,522)
(39%)
31 Dec 2015
13,169,753
-
(12,459,321)
(94.6%)
(10,980,758)
(83.4%)
(13,737,532)
(104.3%)
31 Dec 2016
31 Dec 2017
31 Dec 2018

Unlock the recent years of financials and more for Parnell Pharmaceuticals Holdings Ltd..

Request a demo to see more.

Deals

Deals Type
Buyout
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Parnell Pharmaceuticals Holdings Ltd. 16 Nov 2020
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.